Related Experiment Video
Updated: Jan 18, 2026
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
SeptAlign™ biosorbable implant for correction of mobile cartilaginous nasal septum deviation: A case report
Harry E Zylicz1,2, Caroline Taylor2, William Robertson2
1Sinus and Nasal Specialists of Louisiana, Baton Rouge, Louisiana, United States of America.
Introduction:
The standard of care for symptomatic nasal septal deviation in adults, refractory to medical management, is septoplasty. SeptAlign™ is a minimally-invasive, bioabsorbable implant cleared by the United States Food and Drug Administration for mechanical correction of minor nasal septal deviation and a novel alternative to traditional septoplasty.
Presentation Of Case:
We present a case report of a 42 year old male with a history of symptomatic nasal septal deviation and nasal airway obstruction who strongly wished to avoid open surgical correction.
Discussion:
We successfully implanted the SeptAlign device to correct the cartilaginous deviation with severe anterior caudal deflection. We present pre- and post-procedure computed tomography and endoscopy imaging and patient reported outcomes to demonstrate correction of nasal airway obstruction and symptoms.
Conclusion:
SeptAlign is a less invasive alternative to traditional septoplasty or septorhinoplasty in patients with cartilaginous nasal septal deviation, with the added benefits of avoiding general anesthesia and the convenience of an in-office procedure.
